Coris almost gone11 Jun 2025 08:29
Avacta on verge of becoming a pure therapeutics company which makes the investment case less risky and much easier to understand. CC has previously said becoming a pure Tx play then allows interested II's to onboard. If they want a substantial chunk and heights conversion is being dealt with by Richard then they're going to have to pay a premium.
Of course they could wait until avacta are desperate for cash, which they aren't right now, and the try get a discount but by then we'll have had more than enough data release and potential commercial deal for a partners warhead that either we don't need them OR the share price is much higher and so any discount they get on that is likely higher than one they could negotiate now, even if at a premium to current price.
GSA offer a couple million if they want to close out but then that's it. Things starting to look good here. A stable foundation from which to launch